Skip to main content
SpringerLink
Log in

Role of the Clinical Pharmacist in the Oncologic Intensive Care Unit

  • Living reference work entry
  • First Online:
Book cover Oncologic Critical Care

  • 247 Accesses

Abstract

A clinical pharmacist is an essential and valuable member of the multidisciplinary ICU team. The impact of ICU clinical pharmacy services is well documented in the primary literature, with positive outcomes in areas such as adverse drug events, drug-drug interactions, antimicrobial therapy, anticoagulant therapy, sedation/analgesia therapy, and provision of advanced cardiac life support. Recent research has shown that the presence of clinical pharmacists in ICUs that care for critically ill oncology patients is associated with decreased mortality. Critical care clinical pharmacists who practice in oncology ICUs often face a unique set of circumstances, including high level of patient acuity, complex pharmacotherapeutic regimens, and high volume of medication use. These practitioners should be familiar with the management of oncology-specific disease states and the complications associated with the treatment of malignancy. The integration of clinical pharmacists and clinical pharmacy services in oncology ICUs is imperative.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27:481–93.

    Article  CAS  Google Scholar 

  2. Brilli RJ, et al. Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med. 2001;29:2007–19.

    Article  CAS  Google Scholar 

  3. Chant C, Dewhurst NF, Friedrich JO. Do we need a pharmacist in the ICU? Intensive Care Med. 2015;41:1314–20.

    Article  PubMed  Google Scholar 

  4. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25:1289–97.

    Article  CAS  PubMed  Google Scholar 

  5. Draper HM, Eppert JA. Association of pharmacist presence on compliance with advanced cardiac life support guidelines during in-hospital cardiac arrest. Ann Pharmacother. 2008;42:469–74.

    Article  PubMed  Google Scholar 

  6. Erstad BL, Haas CE, O’Keeffe T, Hokula CA, Parrinello K, Theodorou AA. Interdisciplinary patient care in the intensive care unit: focus on the pharmacist. Pharmacotherapy. 2011;31:128–37.

    Article  PubMed  Google Scholar 

  7. Koch A, Checkley W. Do hospitals need oncological critical care units? J Thorac Dis. 2017;9:E304–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.

    Article  CAS  PubMed  Google Scholar 

  9. MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009;29:761–8.

    Article  PubMed  Google Scholar 

  10. MacLaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA. Critical care pharmacy services in United States hospitals. Ann Pharmacother. 2006;40:612–8.

    Article  PubMed  Google Scholar 

  11. MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:3184–9.

    Article  PubMed  Google Scholar 

  12. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008;36:427–33.

    Article  PubMed  Google Scholar 

  13. Ng TM, et al. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study. Ann Pharmacother. 2008;42: 475–82.

    Article  PubMed  Google Scholar 

  14. Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013;144:1687–95.

    Article  PubMed  Google Scholar 

  15. Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med. 2000;28:3746–50.

    Article  CAS  PubMed  Google Scholar 

  16. Soares M, et al. Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol. 2016;34:3315–24.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Brian M. Dee

Authors
  1. Brian M. Dee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian M. Dee .

Editor information

Editors and Affiliations

  1. Department of Critical Care, University of Texas MD Anderson Cancer C Department of Critical Care, Houston, TX, USA

    Joseph L. Nates

  2. Department of Critical Care, University of Texas MD Anderson Cancer C Department of Critical Care, Houston, TX, USA

    Kristen J. Price

Section Editor information

  1. Clinical Pharmacy Svcs, Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Todd W. Canada

  2. Clinical Pharmacy Specialist – Critical Care / Nutrition Support, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Jeffrey J. Bruno

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Dee, B.M. (2019). Role of the Clinical Pharmacist in the Oncologic Intensive Care Unit. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74698-2_20-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74698-2_20-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74698-2

  • Online ISBN: 978-3-319-74698-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation